Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1863 entries
View as:

Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02615054 Org: User:
Start: 11/18/15 End: 03/05/24 Due: 03/05/25

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00541034 Org: User:
Start: 05/31/05 End: 01/31/16 Due: 01/31/17

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003390 Org: User:
Start: 06/30/98 End: 08/31/04 Due: 08/31/05

PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00045279 Org: User:
Start: 04/30/02 End: 09/30/05 Due: 09/30/06

A Study of Talquetamab for People with Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06066346 Org: User:
Start: 09/27/23 End: 10/31/26 Due: 10/31/27

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02278055 Org: User:
Start: 10/08/14 End: 02/02/22 Due: 02/02/23

Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03662776 Org: User:
Start: 08/31/18 End: 08/31/25 Due: 08/31/26

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06126341 Org: User:
Start: 11/03/23 End: 05/03/29 Due: 05/03/30

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

Phase: N/A Priority: Normal
NCT ID: NCT02608619 Org: User:
Start: 11/30/15 End: 08/31/18 Due: 08/31/19

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02340728 Org: User:
Start: 01/31/15 End: 11/30/19 Due: 11/30/20

PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01269593 Org: User:
Start: 12/31/10 End: 12/31/25 Due: 12/31/26

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03364803 Org: User:
Start: 11/28/17 End: 11/28/25 Due: 11/28/26

Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01025453 Org: User:
Start: 12/01/09 End: 01/16/18 Due: 01/16/19

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Phase: N/A Priority: Normal
NCT ID: NCT00820170 Org: User:
Start: 01/31/09 End: 08/31/18 Due: 08/31/19

Identifying and Measuring Depression in Older Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02174055 Org: User:
Start: 06/20/14 End: 06/30/26 Due: 06/30/27

Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT01399918 Org: User:
Start: 07/31/11 End: 12/28/20 Due: 12/28/21

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03879798 Org: User:
Start: 03/15/19 End: 05/02/23 Due: 05/02/24

Interest and Impact of Skin Cancer Genetic Testing

Phase: N/A Priority: Normal
NCT ID: NCT02941900 Org: User:
Start: 08/31/16 End: 01/18/23 Due: 01/18/24

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00546377 Org: User:
Start: 07/31/05 End: 05/31/14 Due: 05/31/15

Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002691 Org: User:
Start: 08/31/95 End: 06/30/00 Due: 06/30/01

Clinical Significance of Germline BRCA Mutations

Phase: N/A Priority: Normal
NCT ID: NCT00579488 Org: User:
Start: 07/31/96 End: 07/31/25 Due: 07/31/26

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Phase: N/A Priority: Normal
NCT ID: NCT01862315 Org: User:
Start: 05/31/13 End: 03/18/25 Due: 03/18/26

Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04068831 Org: User:
Start: 08/22/19 End: 12/06/23 Due: 12/06/24

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Phase: N/A Priority: Normal
NCT ID: NCT01131169 Org: User:
Start: 05/31/10 End: 05/15/20 Due: 05/15/21

Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT00597610 Org: User:
Start: 11/30/03 End: 09/30/12 Due: 09/30/13